Evidence map›Paper›PMID 21220691›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells.

Alessandra Fragale, Emilia Stellacci, Ramona Ilari, Anna Lisa Remoli, Angela Lanciotti, Edvige Perrotti, Iart Shytaj, Roberto Orsatti, Harshani R Lawrence, Nicholas J Lawrence and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HCFC2 is needed for IRF1- and IRF2-dependentThe Journal of experimental medicine · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 6 countries.

Alessandra FragaleDipartimento di Malattie Infettive, Parassitarie ed Immunomediate, Istituto Superiore di Sanità, Rome, Italy.
Emilia Stellacci
Ramona Ilari
Anna Lisa Remoli
Angela Lanciotti
Edvige Perrotti
Iart Shytaj
Roberto Orsatti
Harshani R Lawrence
Nicholas J Lawrence
Jerry Wu
Michael Rehli
Keiko Ozato
Angela Battistini
Istituto Superiore di Sanità · ITMoffitt Cancer Center · USNational Institute of Child Health · PKUniversity Hospital Regensburg · DE

Funding

Gene Regulation In The Immune SystemZIAHD001310 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI OZATO, KEIKO · 2009 to 2025
$15.0M
Targeting Signal Transduction Pathways for Cancer Drug DiscoveryP01CA118210 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI LAWRENCE, HARSHANI R · 2007 to 2011
$9.8M
NCI NIH HHS P01 CA118210NCI NIH HHS P01CA118210
6 · The paper itself

Abstract

Despite extensive studies that unraveled ligands and signal transduction pathways triggered by TLRs, little is known about the regulation of TLR gene expression. TLR3 plays a crucial role in the recognition of viral pathogens and induction of immune responses by myeloid DCs. IFN regulatory factor (IRF)-8, a member of the IRF family, is a transcriptional regulator that plays essential roles in the development and function of myeloid lineage, affecting different subsets of myeloid DCs. In this study, we show that IRF-8 negatively controls TLR3 gene expression by suppressing IRF-1- and/or polyinosinic-polycytidylic acid-stimulated TLR3 expression in primary human monocyte-derived DCs (MDDCs). MDDCs expressed TLR3 increasingly during their differentiation from monocytes to DCs with a peak at day 5, when TLR3 expression was further enhanced upon stimulation with polyinosinic-polycytidylic acid and then was promptly downregulated. We found that both IRF-1 and IRF-8 bind the human TLR3 promoter during MDDC differentiation in vitro and in vivo but with different kinetic and functional effects. We demonstrate that IRF-8-induced repression of TLR3 is specifically mediated by ligand-activated Src homology 2 domain-containing protein tyrosine phosphatase association. Indeed, Src homology 2 domain-containing protein tyrosine phosphatase-dephosphorylated IRF-8 bound to the human TLR3 promoter competing with IRF-1 and quashing its activity by recruitment of histone deacetylase 3. Our findings identify IRF-8 as a key player in the control of intracellular viral dsRNA-induced responses and highlight a new mechanism for negative regulation of TLR3 expression that can be exploited to block excessive TLR activation.

Indexed as

Dendritic CellsDown-RegulationGene Expression RegulationHumansInterferon Regulatory Factor-8Interferon Regulatory FactorsIntracellular FluidLigandsMyeloid CellsPoly I-CProtein BindingProtein Tyrosine Phosphatase, Non-Receptor Type 2RNA, Viralsrc Homology DomainsToll-Like Receptor 3Interferon Regulatory Factor-8Interferon Regulatory FactorsLigandsPoly I-CProtein Tyrosine Phosphatase, Non-Receptor Type 2PTPN2 protein, humanRNA, ViralTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID21220691
PMCPMC4053178
OpenAlexW2117927173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.